Gastrointestinal Tumor Clinical Trial
Official title:
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
In phase Ia study, the safety and tolerability of BL-B01D1 in patients with locally advanced or metastatic gastrointestinal tumor and other solid tumor will be investigated to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) of BL-B01D1. In phase Ib study, the safety and tolerability of BL-B01D1 at the phase Ia recommended dose will be further investigated, and recommended phase II dose (RP2D) for phase II clinical studies will be determined. In addition, the preliminary efficacy, pharmacokinetic characteristics, and immunogenicity of BL-B01D1 in patients with locally advanced or metastatic gastrointestinal tumor and other solid tumor will be evaluated.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01434069 -
Phase I Trial of Combination of FOLFIRI and SOM 230
|
Phase 1 | |
| Recruiting |
NCT06340620 -
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
|
N/A | |
| Recruiting |
NCT04960072 -
Study on TIL for the Treatment of r/r Gastrointestinal Tumors
|
Early Phase 1 | |
| Completed |
NCT06022692 -
Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours
|
Phase 1/Phase 2 | |
| Completed |
NCT02631590 -
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
|
Phase 2 | |
| Recruiting |
NCT04960943 -
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors
|
Phase 2 | |
| Completed |
NCT01625351 -
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
|
Phase 1 |